BRUSADIN, VALENTINA
 Distribuzione geografica
Continente #
NA - Nord America 297
EU - Europa 59
AS - Asia 21
AF - Africa 3
SA - Sud America 1
Totale 381
Nazione #
US - Stati Uniti d'America 295
SE - Svezia 17
IT - Italia 12
DE - Germania 11
FI - Finlandia 11
IN - India 10
CN - Cina 7
BG - Bulgaria 3
CA - Canada 2
GB - Regno Unito 2
SG - Singapore 2
TG - Togo 2
UA - Ucraina 2
AR - Argentina 1
IE - Irlanda 1
IL - Israele 1
JP - Giappone 1
ZA - Sudafrica 1
Totale 381
Città #
Fairfield 57
Chandler 25
Woodbridge 25
Seattle 23
Cambridge 22
Houston 22
Ashburn 18
Wilmington 15
Grafing 7
Princeton 7
San Paolo di Civitate 7
Boston 6
Lawrence 6
Plano 6
Beijing 5
Helsinki 5
Andover 3
Bremen 3
Cagliari 3
San Diego 3
Sofia 3
Ann Arbor 2
Boardman 2
Lomé 2
New York 2
Tappahannock 2
Atlanta 1
Dublin 1
Federal 1
Fremont 1
Hounslow 1
Jacksonville 1
Kilburn 1
Kunming 1
Leawood 1
Millbury 1
Muizenberg 1
Nanchang 1
Norwalk 1
Nuremberg 1
Ottawa 1
Ponticelli 1
Riva 1
Rome 1
Tel Aviv 1
Tokyo 1
Toronto 1
Washington 1
Totale 303
Nome #
Activity of Adenosine Receptors Type 1 Is Required for CX3CL1-Mediated Neuroprotection and Neuromodulation in Hippocampal Neurons. 75
Non-opioid induction of morphine-6-glucuronide synthesis is elicited by prolonged exposure of rat hepatocytes to heroin 73
Induction of morphine-6-glucuronide synthesis by heroin self-administration in the rat 64
Adenosine A1 receptors and microglial cells mediate CX3CL1-induced protection of hippocampal neurons against Glu-induced death. 60
Repeated exposure to codeine alters morphine glucuronidation by affecting UGT gene expression in the rat 57
In vivo chronic exposure to heroin or naltrexone selectively inhibits liver microsome formation of estradiol-3-glucuronide in the rat 54
Totale 383
Categoria #
all - tutte 1.022
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.022


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202085 0 0 1 5 12 11 13 15 15 6 4 3
2020/202128 3 4 0 3 2 1 1 1 9 3 1 0
2021/202264 0 6 6 2 6 0 1 9 2 1 20 11
2022/202390 13 19 4 15 6 7 4 5 11 2 4 0
2023/202428 0 6 1 4 3 7 2 2 0 3 0 0
2024/20251 1 0 0 0 0 0 0 0 0 0 0 0
Totale 383